Imidazoquinoxaline anticancer derivatives and imiquimod interact with tubulin: Characterization of molecular microtubule inhibiting mechanisms in correlation with cytotoxicity.

about

A Novel Interaction Between the TLR7 and a Colchicine Derivative Revealed Through a Computational and Experimental Study.

P2860

Q49805153-AFFFD40C-32CD-43E7-B068-E4D78B77793A

P2860

Imidazoquinoxaline anticancer derivatives and imiquimod interact with tubulin: Characterization of molecular microtubule inhibiting mechanisms in correlation with cytotoxicity.

Item

http://www.wikidata.org/entity/Q41349651

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Imidazoquinoxaline anticancer ...... correlation with cytotoxicity.

@en

type

Item

label

Imidazoquinoxaline anticancer ...... correlation with cytotoxicity.

@en

prefLabel

Imidazoquinoxaline anticancer ...... correlation with cytotoxicity.

@en

P1476

Imidazoquinoxaline anticancer ...... correlation with cytotoxicity

@en

P2093

Carine Deleuze-Masquefa

http://www.w3.org/2001/XMLSchema#string

Caroline Constant

http://www.w3.org/2001/XMLSchema#string

Christian Larroque

http://www.w3.org/2001/XMLSchema#string

Florence Gattacceca

http://www.w3.org/2001/XMLSchema#string

Nicole Bec

http://www.w3.org/2001/XMLSchema#string

Safia El Messaoudi

http://www.w3.org/2001/XMLSchema#string

Zahraa Zghaib

http://www.w3.org/2001/XMLSchema#string

P2860

ZINC--a free database of commercially available compounds for virtual screening

The novel microtubule-destabilizing drug BAL27862 binds to the colchicine site of tubulin with distinct effects on microtubule organization

AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

Microtubules as a target for anticancer drugs

Imiquimod: mode of action

S9, a novel anticancer agent, exerts its anti-proliferative activity by interfering with both PI3K-Akt-mTOR signaling and microtubule cytoskeleton

Python: a programming language for software integration and development

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

Drug combination studies and their synergy quantification using the Chou-Talalay method

P304

e0182022

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0182022

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alexis Courbet

Sonia Khier

Martine Pugniere

P577

2017-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28797090

http://www.w3.org/2001/XMLSchema#string

P932

5552358

http://www.w3.org/2001/XMLSchema#string

Imidazoquinoxaline anticancer derivatives and imiquimod interact with tubulin: Characterization of molecular microtubule inhibiting mechanisms in correlation with cytotoxicity.

about

P2860

P2860

Imidazoquinoxaline anticancer derivatives and imiquimod interact with tubulin: Characterization of molecular microtubule inhibiting mechanisms in correlation with cytotoxicity.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932